•
INTRODUCTION

S
ilicone oil (SO) has been commonly used as a longterm tamponade agent after pars plana vitrectomy for more than fifty years [1] [2] . Although SO endotamponade acts effectively for retinal reattachment, the occurrence of postoperative complications was one of the main concerns for the surgeons. The well-known complications of SO included: secondary glaucoma, cataract formation/deterioration, bandshaped degeneration of the cornea, emulsification, migration to the anterior chamber or subretinal space, retinal toxicity, etc [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] . Therefore, SO removal is usually scheduled once anatomic success is achieved, or at the inevitable occurrence of complication. The most advised time to have SO removal is 4-6mo after SO injection [1, 5, 9, [12] [13] [14] . In our clinical practice two years ago, we noticed that the occurrence of SO emulsification became earlier and more frequent than before. SO emulsification has been found to be related with various factors, including intravitreal hemorrhage and inflammatory reaction, etc [1, 4, 12, [15] [16] [17] . Although SO emulsification is an inherent problem if it remains intravitreally for prolonged duration, the earlier occurrence of which would cause more unscheduled surgical interventions and possibly unsatisfactory retinal reattachment. Therefore, we conducted the current study to find out the factors related to earlier SO emulsification. 
SUBJECTS AND METHODS
Ethical Approval
=55.136, P<0.001).
The results of the logistic regression were listed in Table 1 . DISCUSSION Emulsification of SO can lead to various complications, including glaucoma, inflammation, and PVR formation and progression [1, 5, [8] [9] [10] . The current study is up to date the first one reporting earlier SO emulsification related to one specific brand and type of SO. SO was firstly introduced as an internal tamponading agent in 1961 [2] . It has served as an invaluable tool to the retinal surgeon in the surgical treatment of vitreoretinal disorders under complex status, especially those with severe PVR. Nowadays, various types and brands of SO have obtained approval for ophthalmic use. However, there is still no international standard for the manufacturing process and the purity grading of SO product. In China, multiple kinds of SO are being used in the large number of vitreoretinal patients [5, [13] [14] [18] [19] . SO is generally classified into different types according to their average viscosities and specific gravities. While we should keep in mind that the commercially available SOs are of mixture of compounds, viscosity is judged by measuring the overall average value. The lower-molecularweight SO tends to occur emulsification, which is consistent with the result in the current study [1, 4, 17] . Emulsification of SO is an inherent problem. Emulsification is reported to occur as quickly as 1wk after the initial surgery [1] . Although SO emulsification seems an inevitable postoperative complication of SO tamponading, it should be noted that earlier emulsification would be a negative effect for the vitreoretinal recovery. The ideal timing for SO emulsification is generally considered as more than three months after surgery. We should have some physic knowledge of SO emulsification at the current scenario. Dispersion of SO refers to the breaking up of large bubbles into the smaller ones. Emulsifications only occurs when surface tension of the droplets is reduced in the presence of surfactants. The potential surfactants include phospholipid, protein, lipoprotein. Therefore, the current study collected the general characteristics and specific factors into considerations, to find out the underlying factor related to the phenomenon of earlier SO emulsification. Finally, we found out that the Siluron 2000c (Gueder ® ; Fluoron GmbH; Ulm, Germany) SO was one independent factor related with earlier emulsification of SO. The underlying mechanism is warranted further investigations. Apart from that, other unusual but challenging complications of SO tamponade should be paid attention [20] [21] [22] . Although we have tried our best effort to find out the independent factor causing the unfavorable complication, there are several limitations of the current study should be acknowledged. As earlier emulsification of SO is a unfavorable condition, the current study could only be designed as a retrospective one. Prospective or randomized design was not acceptable at that scenario. It would not be highly convincing to have the conclusion that one specific type of SO was directly correlated with earlier emulsification of SO in the current study, due to the known limitations of the current study.
In conclusion, the current study revealed that the Siluron 2000c (Gueder ® ; Fluoron GmbH; Ulm, Germany) SO is the independent significant factor related to earlier SO emulsification in our hospital. The application of it has be paused after we observed this unusual phenomenon. We are looking forwards to a multi-center analysis of different brands and types of SO to have better conclusion of the factors related to earlier emulsification of SO.
